RYRAX
Price
$52.14
Change
+$0.55 (+1.07%)
Updated
Jul 2 closing price
Net Assets
4.62M
USLUX
Price
$21.05
Change
+$0.19 (+0.91%)
Updated
Jul 2 closing price
Net Assets
51.79M
Interact to see
Advertisement

RYRAX vs USLUX

RYRAX vs USLUX Comparison Chart in %
View a ticker or compare two or three
VS
RYRAX vs. USLUX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYRAX is a Buy and USLUX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
USLUX has more cash in the bank: 51.8M vs. RYRAX (4.63M). RYRAX pays higher dividends than USLUX: RYRAX (1.93) vs USLUX (0.01). RYRAX was incepted earlier than USLUX: RYRAX (28 years) vs USLUX (32 years). USLUX (1.95) is less costly to investors than RYRAX (1.69). RYRAX is a more actively managed with annual turnover of: 296.00 vs. USLUX (122.00). RYRAX has a lower initial minimum investment than USLUX: RYRAX (2500) vs USLUX (5000). RYRAX annual gain was more profitable for investors over the last year : 3.79 vs. USLUX (-3.66). RYRAX return over 5 years is better than : -3.62 vs. USLUX (-7.52).
RYRAXUSLUXRYRAX / USLUX
Total Expense Ratio1.641.7594%
Annual Report Gross Expense Ratio1.691.9587%
Fund Existence28 years32 years-
Gain YTD-0.534-3.48515%
Front LoadN/AN/A-
Min. Initial Investment2500500050%
Min. Initial Investment IRA1000N/A-
Net Assets4.63M51.8M9%
Annual Yield % from dividends1.930.0136,181%
Returns for 1 year3.79-3.66-104%
Returns for 3 years34.526.44536%
Returns for 5 years-3.62-7.5248%
Returns for 10 years122.3824.41501%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOPAX22.700.28
+1.25%
Fidelity Advisor Intl Sm Cap Opps A
BASVX16.050.03
+0.19%
Brown Advisory Sustainable Val Inst
ERBCX19.450.01
+0.05%
Eaton Vance Equity Strategy C
CPTUX93.64-1.71
-1.79%
Invesco Discovery Large Cap R5
EEMFX12.08-0.29
-2.34%
MFS Emerging Markets Equity Research R3